This is great news as more countries will be able to produce the AstraZeneca vaccine and these vaccines can be rolled out globally through COVAX (read more). 

However, there is still much work to do and it would be great if the other Drug Companies followed AstraZeneca's lead.

"But we must keep up the pressure to meet the needs of priority populations everywhere and facilitate global access. To do that, we need two things – a scale-up of manufacturing capacity, and developers’ early submission of their vaccines for WHO review.”

The WHO EUL process can be carried out quickly when vaccine developers submit the full data required by WHO in a timely manner. Once those data are submitted, WHO can rapidly assemble its evaluation team and regulators from around the world to assess the information and, when necessary, carry out inspections of manufacturing sites."